Page last updated: 2024-11-12

1-azafagomine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

1-azafagomine: inhibits processing glycosidase; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10329422
SCHEMBL ID12232221
MeSH IDM0371664

Synonyms (9)

Synonym
azafagomine
2J7H
SCHEMBL12232221
(3r,4r,5r)-3-(hydroxymethyl)hexahydropyridazine-4,5-diol
193540-72-6
(3r,4r,5r)-3-(hydroxymethyl)diazinane-4,5-diol
1-azafagomine
Q27458140
4,5-pyridazinediol,hexahydro-3-(hydroxymethyl)-,(3r,4r,5r)-rel-(9ci)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]